Objective: To investigate the weight losing, antihyperlipidemic and cardioprotective effects of the alkaloid fraction of Hunteria umbellata(H. umbellata) seed.Methods: Adult female Wistar rats(weight range: 120-150 g)...Objective: To investigate the weight losing, antihyperlipidemic and cardioprotective effects of the alkaloid fraction of Hunteria umbellata(H. umbellata) seed.Methods: Adult female Wistar rats(weight range: 120-150 g) were randomly divided into 4 and 5 treatment groups in the normal and triton-induced hyperlipidemic models, respectively. and were daily treated for 14 d before they were humanely sacrificed under inhaled diethyl ether anesthesia. About 5 mL of whole blood was obtained by cardiac puncture from each treated rat, from which serum for lipids assay was subsequently separated. Tissue samples of livers of treated rats were harvested and processed for histopathological analysis.Results: Repeated daily oral treatments of normal rats with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata resulted in significant(P<0.05 and P<0.001) and dose-dependent weight loss, and decreases in the serum triglyceride, total cholesterol and low density lipoprotein cholesterol, while significantly(P<0.001) increased the serum levels of high density lipoprotein cholesterol fraction. Similarly, oral pre-treatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata for 14 d before induction of hyperlipidemia with triton WR-1339 significantly(P<0.01, P<0.001) and dose-dependently attenuated increases in the average body weights, serum levels of triglyceride, total cholesterol and low density lipoprotein cholesterol while also significantly(P<0.01, P<0.001) and dose-dependently attenuated significant(P<0.001) decrease in the serum high-density lipoproteincholesterol levels when compared to the untreated control values. However, the results obtained for 50 mg/kg of alkaloid fraction of H. umbellata in both normal and triton WR-1339-induced hyperlipidemic rats were comparable to that recorded for 20 mg/kg of simvastatin. Similarly, oral pretreatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata significantly improved the histological lesions of fatty hepatic degeneration induced by triton WR-1339 treatment.Conclusions: Overall, results of this study showed that repeated oral treatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata elicited weight losing, antihyperlipidemic and cardioprotective effects in triton WR-1339 induced hyperlipidemic rats that were mediated via de novo cholesterol biosynthesis inhibition.展开更多
Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of ...Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of Red Fuji Apple and contents of individual polyphenols in APE were determined using highperformance liquid chromatography-mass spectrometry（HPLC-MS）.Secondly,forty male National Institude of Health（NIH）mice were randomly divided into 5 groups with 8 animals in each group.The Fenofibrate Capsules（FC）group and APE groups received oral administration of respective drugs for 7 consecutive days.All mice except those in the normal group were intravenously injected through tail vein with Triton WR-1339 on the6th day.Serum and livers from all the mice were obtained 18 h after the injection.The changes in serum total cholesterol（TC）,triglyceride（TG）,lipoprotein lipase（LPL）and hepatic triglyceride lipase（HTGL）were measured by respective kits.Finally,expression of hepatic peroxisome proliferator-activated receptor alpha（PPARα）mRNA was measured by real-time reverse transcription-polymerase chain reaction（RT-PCR）method.Results：Serum TC and TG levels significantly increased in Triton WR-1339-induced model group compared with the normal group（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently reduced the serum level of TG in hyperlipidemic mice（P〈0.01）.Serum LPL and HTGL activities significantly decreased in Triton WR-1339-induced model group compared with the normal group（P〈0.05）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the serum activity of LPL in hyperlipidemic mice（P〈0.05or P〈0.01）.Furthermore,compared with the normal group,hepatic mRNA level of PPARαin the model group significantly decreased（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the expression of PPARαin hyperlipidemic mice（P〈0.05 or P〈0.01）.Conclusion：APE could reduce TG level via up-regulation of LPL activity,which provides new evidence to elucidate the anti-hyperlipidemic effects of APE.展开更多
基金Supported by Institute of International Education(IIE ID:15101139)
文摘Objective: To investigate the weight losing, antihyperlipidemic and cardioprotective effects of the alkaloid fraction of Hunteria umbellata(H. umbellata) seed.Methods: Adult female Wistar rats(weight range: 120-150 g) were randomly divided into 4 and 5 treatment groups in the normal and triton-induced hyperlipidemic models, respectively. and were daily treated for 14 d before they were humanely sacrificed under inhaled diethyl ether anesthesia. About 5 mL of whole blood was obtained by cardiac puncture from each treated rat, from which serum for lipids assay was subsequently separated. Tissue samples of livers of treated rats were harvested and processed for histopathological analysis.Results: Repeated daily oral treatments of normal rats with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata resulted in significant(P<0.05 and P<0.001) and dose-dependent weight loss, and decreases in the serum triglyceride, total cholesterol and low density lipoprotein cholesterol, while significantly(P<0.001) increased the serum levels of high density lipoprotein cholesterol fraction. Similarly, oral pre-treatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata for 14 d before induction of hyperlipidemia with triton WR-1339 significantly(P<0.01, P<0.001) and dose-dependently attenuated increases in the average body weights, serum levels of triglyceride, total cholesterol and low density lipoprotein cholesterol while also significantly(P<0.01, P<0.001) and dose-dependently attenuated significant(P<0.001) decrease in the serum high-density lipoproteincholesterol levels when compared to the untreated control values. However, the results obtained for 50 mg/kg of alkaloid fraction of H. umbellata in both normal and triton WR-1339-induced hyperlipidemic rats were comparable to that recorded for 20 mg/kg of simvastatin. Similarly, oral pretreatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata significantly improved the histological lesions of fatty hepatic degeneration induced by triton WR-1339 treatment.Conclusions: Overall, results of this study showed that repeated oral treatments with 25 and 50 mg/kg/day of alkaloid fraction of H. umbellata elicited weight losing, antihyperlipidemic and cardioprotective effects in triton WR-1339 induced hyperlipidemic rats that were mediated via de novo cholesterol biosynthesis inhibition.
文摘Objective：To investigate the anti-hyperlipidemic effects of apple polyphenols extract（APE）in Triton WR-1339-induced endogenous hyperlipidemic model.Methods：Firstly,APE was isolated and purified from the pomace of Red Fuji Apple and contents of individual polyphenols in APE were determined using highperformance liquid chromatography-mass spectrometry（HPLC-MS）.Secondly,forty male National Institude of Health（NIH）mice were randomly divided into 5 groups with 8 animals in each group.The Fenofibrate Capsules（FC）group and APE groups received oral administration of respective drugs for 7 consecutive days.All mice except those in the normal group were intravenously injected through tail vein with Triton WR-1339 on the6th day.Serum and livers from all the mice were obtained 18 h after the injection.The changes in serum total cholesterol（TC）,triglyceride（TG）,lipoprotein lipase（LPL）and hepatic triglyceride lipase（HTGL）were measured by respective kits.Finally,expression of hepatic peroxisome proliferator-activated receptor alpha（PPARα）mRNA was measured by real-time reverse transcription-polymerase chain reaction（RT-PCR）method.Results：Serum TC and TG levels significantly increased in Triton WR-1339-induced model group compared with the normal group（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently reduced the serum level of TG in hyperlipidemic mice（P〈0.01）.Serum LPL and HTGL activities significantly decreased in Triton WR-1339-induced model group compared with the normal group（P〈0.05）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the serum activity of LPL in hyperlipidemic mice（P〈0.05or P〈0.01）.Furthermore,compared with the normal group,hepatic mRNA level of PPARαin the model group significantly decreased（P〈0.01）.Oral administration of APE[200 and 400 mg/（kg·day）]dose-dependently elevated the expression of PPARαin hyperlipidemic mice（P〈0.05 or P〈0.01）.Conclusion：APE could reduce TG level via up-regulation of LPL activity,which provides new evidence to elucidate the anti-hyperlipidemic effects of APE.
